CytomX Therapeutics, Inc. — Form D

CytomX Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-28. The offering totals $30.0M, of which $10.0M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Matthew YoungDirectorJupiter, FL
Nancy StaglianoDirectorSouth San Francisco, CA
Nancy StaglianoExecutive OfficerSouth San Francisco, CA
Sean McCarthyDirectorSouth San Francisco, CA
Sean McCarthyExecutive OfficerSouth San Francisco, CA
Mani MohindruDirectorPittsburgh, PA
Chris OgdenExecutive OfficerSOUTH SAN FRANCISCO, CA
Marcia BelvinExecutive OfficerSOUTH SAN FRANCISCO, CA
James MeyersDirectorSOUTH SAN FRANCISCO, CA
Alan AshworthDirectorSOUTH SAN FRANCISCO, CA
Jeff LandauExecutive OfficerSOUTH SAN FRANCISCO, CA
Halley GilbertDirectorSOUTH SAN FRANCISCO, CA
Wayne ChuExecutive OfficerSOUTH SAN FRANCISCO, CA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Lloyd RowlandExecutive OfficerSOUTH SAN FRANCISCO, CA
Frederick GluckDirectorWestlake Village, CA
Frederick GluckExecutive OfficerWestlake Village, CA
Gary WilcoxDirectorThousand Oaks, CA
Tim W ShannonDirectorNew Haven, CT
Rachel V HumphreyDirectorSouth San Francisco, CA
Hoyoung W HuhDirectorSouth San Francisco, CA
Neil W ExterDirectorSouth San Francisco, CA
Alan HeegerDirectorSanta Barbara, CA
Elaine V JonesDirectorAustin, TX
Frederick W GluckDirectorThousand Oaks, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2023-08-17D$30.0M$30.0M
2015-06-25D$70.0M$70.0M
2015-01-06D$30.0M$16.5M
2012-08-10D$26.0M$12.6M
2010-09-28D$653K$653K
2010-09-28D$2.7M$2.7M
2010-09-28D$102K$102K
2010-09-28D$525K$525K

More